摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-苯基四唑-2-基乙酸酰胺 | 25468-24-0

中文名称
5-苯基四唑-2-基乙酸酰胺
中文别名
——
英文名称
5-phenyltetrazol-2-ylethanoic acid amide
英文别名
2-(5-phenyl-2H-tetrazol-2-yl)acetamide;5-phenyl-2-tetrazolylacetic acid amide;(5-phenyltetrazol-2-yl)acetamide;5-phenyl-2-tetrazolylacetamide;2-(5-phenyl-tetrazol-2-yl)-acetamide;2-(5-phenyltetrazol-2-yl)acetamide
5-苯基四唑-2-基乙酸酰胺化学式
CAS
25468-24-0
化学式
C9H9N5O
mdl
MFCD02047949
分子量
203.203
InChiKey
SFMRLZQXQSMOJK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    186-186.5 °C(Solv: water (7732-18-5); ethanol (64-17-5))
  • 沸点:
    482.9±47.0 °C(Predicted)
  • 密度:
    1.45±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.111
  • 拓扑面积:
    86.7
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 신규 N-아실유레아 유도체 및 이를 함유하는 심혈관질환의 예방 또는 치료용 조성물
    申请人:Korea University Research and Business Foundation 고려대학교 산학협력단(220040170680) BRN ▼209-82-08298
    公开号:KR101691954B1
    公开(公告)日:2017-01-02
    본 발명은 신규 N-아실유레아 유도체 및 이의 심혈관질환의 치료 또는 예방 용도에 관한 것으로, 더욱 자세하게는 신규 N-아실유레아 유도체, 상기 N-acylurea 유도체를 유효성분으로 함유하는 심혈관질환의 예방 또는 치료용 약학적 조성물 및 N-아실유레아 유도체의 제조방법에 관한 것으로, 본 발명에 따른 N-acylurea 유도체는 세포내 기질 (intracellular matrix)의 탈린 작용을 억제하여 혈소판 응집을 저해할 수 있으므로 심혈관질환의 예방 또는 치료에 유용하게 사용할 수 있다.
    该专利涉及新型N-酰基生物及其在心血管疾病的治疗或预防中的用途,更具体地说,涉及新型N-酰基生物,包含上述N-酰基生物作为有效成分的用于心血管疾病预防或治疗的药学组合物,以及关于N-酰基生物的制备方法,根据本发明的N-酰基生物能够抑制细胞内基质的塔林作用,从而可以有效用于心血管疾病的预防或治疗。
  • Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages
    申请人:Michelet Jean-Francois
    公开号:US20060034786A1
    公开(公告)日:2006-02-16
    Inhibitors of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), for example tetrazole, styrylpyrazole, phenylfuran, phenylthiophene, phenylpyrrazole, pyrazolecarboxamide, 2-thioacetamide and azo compounds, are useful for promoting or stimulating pigmentation of the skin and/or skin appendages and/or for preventing and/or for limiting depigmentation and/or whitening of the skin and/or skin appendages, notably for preventing and/or limiting canities.
    15-羟基前列腺素脱氢酶(15-PGDH)的抑制剂,例如四唑、苯基吡唑、苯基呋喃、苯基噻吩、苯基吡唑吡唑羧酰胺、2-代乙酰胺和偶氮化合物,可用于促进或刺激皮肤和/或皮肤附属物的色素沉淀和/或预防和/或限制皮肤和/或皮肤附属物的脱色和/或变白,特别是用于预防和/或限制白发。
  • INHIBITORS OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE FOR STIMULATING PIGMENTATION OF THE SKIN OR SKIN APPENDAGES
    申请人:MICHELET JEAN-FRANCOIS
    公开号:US20110014250A1
    公开(公告)日:2011-01-20
    Inhibitors of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), for example tetrazole, styrylpyrazole, phenylfuran, phenylthiophene, phenylpyrrazole, pyrazolecarboxamide, 2-thioacetamide and azo compounds, are useful for promoting or stimulating pigmentation of the skin and/or skin appendages and/or for preventing and/or for limiting depigmentation and/or whitening of the skin and/or skin appendages, notably for preventing and/or limiting canities.
    15-羟基前列腺素脱氢酶(15-PGDH)的抑制剂,例如四唑苯乙烯吡唑苯并呋喃、苯并吩、苯并吡唑吡唑羧酰胺、2-代乙酰胺和偶氮化合物,可用于促进或刺激皮肤和/或皮肤附属物的色素沉着,或预防和/或限制皮肤和/或皮肤附属物的脱色和/或变白,特别是预防和/或限制白发。
  • Synthesis, Structure, and Antiproliferative Activity of trans-Palladium(II) Complexes with Tetrazol-2-ylacetic Acid Derivatives
    作者:E. A. Popova、O. V. Mikolaichuk、A. V. Protas、A. V. Mukhametshina、G. K. Ovsepyan、G. L. Starova、R. V. Suezov、A. V. Fonin、R. E. Trifonov
    DOI:10.1134/s1070363218110178
    日期:2018.11
    A series of trans-palladium(II) complexes (trans-[PdCl2L2], L = ethyl 5-R-2H-tetrazol-2-ylacetate, 5-R-2H-tetrazol-2-ylacetamides, R = Me, Ph) has been synthesized, and their structure has been proved by 1H and 13C–1H} NMR and high-resolution mass spectra and X-ray analysis. Antiproliferative activity of the synthesized complexes has been determined, and the mechanism of their interaction with DNA
    一系列反式(II)配合物(反式[PdCl 2 L 2 ],L = 5-R-2 H-四唑-2-基乙酸乙酯,5-R-2 H-四唑-2-基乙酰胺,R = Me,Ph)已合成,其结构已通过1 H和13 C– 1 H} NMR,高分辨率质谱和X射线分析证明。已经确定了合成复合物的抗增殖活性,并通过紫外和CD光谱研究了它们与DNA的相互作用机理。
  • Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
    申请人:SOCIETE L'OREAL S.A.
    公开号:US20040052760A1
    公开(公告)日:2004-03-18
    The invention relates to a cosmetic composition containing at least one 15-hydroxyprostaglandin dehydrogenase inhibitor and cosmetically acceptable excipients. It also relates to a method of cosmetic treatment for promoting the growth and/or preventing or delaying the loss of hair, and the use of a 15-hydroxyprostaglandin dehydrogenase inhibitor for the preparation of a composition intended for controlling hair loss and/or for promoting hair regrowth.
    本发明涉及一种化妆品组合物,其含有至少一种15-羟基前列腺素脱氢酶抑制剂和化妆品可接受的辅料。本发明还涉及一种促进头发生长和/或预防或延迟脱发的化妆品治疗方法,以及使用15-羟基前列腺素脱氢酶抑制剂制备用于控制脱发和/或促进头发再生的组合物的用途。
查看更多